Article(id=1329905863084584993, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905851004990344, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2025.09.003, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1739721600000, receivedDateStr=2025-02-17, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795003866215, onlineDateStr=2026-11-18, pubDate=1757433600000, pubDateStr=2025-09-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795003866215, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795003866215, creator=13701087609, updateTime=1795003866215, updator=13701087609, issue=Issue{id=1329905851004990344, tenantId=1146029695717560320, journalId=1319690259887390882, year='2025', volume='56', issue='9', pageStart='1109', pageEnd='1242', issueExtLink='null', onlineDate='null', pubDate='1757433600000', pubDateStr='2025-09-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=0, createTime=1795003863334, creator='13701087609', updateTime=1795004352009, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329907901218533896, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905851004990344, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329907901218533897, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905851004990344, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1129, endPage=1138, ext={EN=ArticleExt(id=1329905863294300194, articleId=1329905863084584993, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Study on Synthesis Process of Linagliptin and Its Related Substances, columnId=1322624454216238014, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Paper, runingTitle=null, highlight=null, articleAbstract=

The synthesis process of the antihyperglycemic drug linagliptin(1) was optimized, and the key process parameters for each step were determined, along with the impurities generated. Starting from 8-bromo-7-(but-2-yn-1-yl)-3-methylxanthine(3), crude 1 was obtained through a two-step substitution reaction and deprotection. The pure target 1 was afforded by recrystallization from ethanol with an overall yield of 74.6%(based on 3) and HPLC purity of 99.85%, while individual impurity below 0.05%. By replacing the deprotection reagent with trimethylsilyl trifluoromethanesulfonate(TMSOTf), the process was stabilized and simplified, significantly reducing the formation of the dimer impurity of 1 (namely related substance B). This optimized process was suitable for industrial production. Furthermore, nine related substances were synthesized, among which the synthetic routes of related substances A, C, D, E, F, G, H, and I were reported at the first time. This study is expected to provide a valuable reference for the quality control of 1 .

, authors=Bing WANG, Zhen LI, Lintao XIA, Yongjian CHI, Zhong LI*, authorsList=Bing WANG, Zhen LI, Lintao XIA, Yongjian CHI, Zhong LI, authorCompany=null, correspAuthors=Zhong LI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329905863566929955, articleId=1329905863084584993, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=利格列汀的合成工艺及其有关物质研究, columnId=1322624454384010176, journalTitle=中国医药工业杂志, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=

对降血糖药利格列汀(1)的合成工艺进行了优化,并确定了各步关键工艺参数及产生的杂质。以8-溴-7-(2-丁炔基)-3-甲基黄嘌呤(3)为原料,经2步取代反应、脱保护得1粗品,经乙醇重结晶得1精品。总收率74.6%(以3计),HPLC纯度99.85%,单杂小于0.05%。该工艺将脱保护试剂改为三氟甲磺酸三甲基硅酯(TMSOTf),工艺稳定,操作简单,可大幅度减少1的二聚体杂质(即有关物质B)的生成,适合工业化生产。该研究合成了9个有关物质,其中有关物质A、C、D、E、F、G、H和I的合成路线为自主设计,可为1的质量控制提供一定的参考。

, authors=王兵, 李震, 夏林涛, 迟永建, 李忠*, authorsList=王兵, 李震, 夏林涛, 迟永建, 李忠, authorCompany=null, correspAuthors=李忠, authorNote=

王兵,硕士,工程师,从事药品合成工艺与质量研究。

, correspAuthorsNote=
李忠,博士,工程师,从事药品合成工艺与质量研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=TRX8F9zvMpqPj2dKIEdhQg==, magXml=h4jy5fMo4bOJr5tq1ae18w==, pdfUrl=null, pdf=u1RdZnYMtKmL8BWAlA+4gQ==, pdfFileSize=1122105, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=yz8KDlU/NzNJtMslDJs2Vg==, mapNumber=null, fund=null)}, authors=[Author(id=1329905863852142632, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905863952805930, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, authorId=1329905863852142632, language=EN, stringName=Bing WANG, firstName=Bing, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905864082829355, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, authorId=1329905863852142632, language=CN, stringName=王兵, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035, bio={"content":"

王兵,硕士,工程师,从事药品合成工艺与质量研究。

"}, bioImg=null, bioContent=

王兵,硕士,工程师,从事药品合成工艺与质量研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905863764062244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, xref=null, ext=[AuthorCompanyExt(id=1329905863772450853, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035), AuthorCompanyExt(id=1329905863780839462, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035)])]), Author(id=1329905864204464173, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905864309321775, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, authorId=1329905864204464173, language=EN, stringName=Zhen LI, firstName=Zhen, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905864376430640, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, authorId=1329905864204464173, language=CN, stringName=李震, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905863764062244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, xref=null, ext=[AuthorCompanyExt(id=1329905863772450853, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035), AuthorCompanyExt(id=1329905863780839462, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035)])]), Author(id=1329905864443539506, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905864527425588, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, authorId=1329905864443539506, language=EN, stringName=Lintao XIA, firstName=Lintao, middleName=null, lastName=XIA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905864598728757, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, authorId=1329905864443539506, language=CN, stringName=夏林涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905863764062244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, xref=null, ext=[AuthorCompanyExt(id=1329905863772450853, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035), AuthorCompanyExt(id=1329905863780839462, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035)])]), Author(id=1329905864678420535, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905864795861049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, authorId=1329905864678420535, language=EN, stringName=Yongjian CHI, firstName=Yongjian, middleName=null, lastName=CHI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905864875552826, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, authorId=1329905864678420535, language=CN, stringName=迟永建, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905863764062244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, xref=null, ext=[AuthorCompanyExt(id=1329905863772450853, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035), AuthorCompanyExt(id=1329905863780839462, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035)])]), Author(id=1329905864967827516, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329905865085268030, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, authorId=1329905864967827516, language=EN, stringName=Zhong LI, firstName=Zhong, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905865211097151, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, authorId=1329905864967827516, language=CN, stringName=李忠, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905863764062244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, xref=null, ext=[AuthorCompanyExt(id=1329905863772450853, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035), AuthorCompanyExt(id=1329905863780839462, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035)])])], keywords=[Keyword(id=1329905865349509184, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, language=EN, orderNo=1, keyword=linagliptin), Keyword(id=1329905865420812353, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, language=EN, orderNo=2, keyword=antihyperglycemics), Keyword(id=1329905865487921218, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, language=EN, orderNo=3, keyword=dipeptidyl peptidaseⅣ inhibitor), Keyword(id=1329905865605361731, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, language=EN, orderNo=4, keyword=type 2 diabetes), Keyword(id=1329905865676664900, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, language=EN, orderNo=5, keyword=related substance), Keyword(id=1329905865743773765, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, language=EN, orderNo=6, keyword=synthesis process), Keyword(id=1329905865798299718, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, language=CN, orderNo=1, keyword=利格列汀), Keyword(id=1329905865869602887, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, language=CN, orderNo=2, keyword=降血糖药), Keyword(id=1329905865936711752, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, language=CN, orderNo=3, keyword=二肽基肽酶Ⅳ抑制剂), Keyword(id=1329905866003820617, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, language=CN, orderNo=4, keyword=2型糖尿病), Keyword(id=1329905866079318090, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, language=CN, orderNo=5, keyword=有关物质), Keyword(id=1329905866171592779, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, language=CN, orderNo=6, keyword=合成工艺)], refs=[Reference(id=1329905866301616204, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=ECKHARDT M, LANGKOPF E, MARK M, et al.8-(3-(R)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione, a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes [J].J Med Chem, 2007, 50(26): 6450-6453., articleTitle=null, refAbstract=null), Reference(id=1329905866398085197, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=THOMAS L, ECKHARDT M E, LANGKOPF E, et al.(R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3- methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione(BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors [J].J Pharmacol Exp Ther, 2008, 325(1): 175-182., articleTitle=null, refAbstract=null), Reference(id=1329905866490359886, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=PENNO G, GAROFOLO M, DEL PRATO S.Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injury [J].Nutr Metab Cardiovasc Dis, 2016, 26(5): 361-373., articleTitle=null, refAbstract=null), Reference(id=1329905866561663055, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=LAJARA R.Use of the dipeptidyl peptidase-4 inhibitor linagliptin in combination therapy for type 2 diabetes [J].Expert Opin Pharmacother, 2012, 13(18): 2663-2671., articleTitle=null, refAbstract=null), Reference(id=1329905866641354832, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=SHEU W H H, PARK S W, GONG Y, et al.Linagliptin improves glycemic control after 1 year as add-on therapy to basal insulin in Asian patients with type 2 diabetes mellitus[J].Curr Med Res Opin, 2015, 31(3): 503-512., articleTitle=null, refAbstract=null), Reference(id=1329905866771378257, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=王 悦, 郭 珩, 岑均达, 等. 利格列汀合成路线图解[J].中国医药工业杂志, 2014, 45(11): 1093-1096., articleTitle=null, refAbstract=null), Reference(id=1329905866867847250, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Boehringer Ingelheim Pharma GmbH & Co.KG.Preparation of 8-[3-amino piperidin-1-yl] xanthines, the production thereof and the use of the same as medicaments:WO, 2004018468A2 [P].2004-03-04., articleTitle=null, refAbstract=null), Reference(id=1329905866939150419, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=刘明媚, 李婉婷, 黄 强, 等.利拉利汀的合成工艺研究[J].中国药物化学杂志, 2015, 25(4): 275-279., articleTitle=null, refAbstract=null), Reference(id=1329905867023036500, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Boehringer Ingelheim International GmbH.Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines: WO, 2006048427 [P].2006-05-11., articleTitle=null, refAbstract=null), Reference(id=1329905867119505493, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=贝林格尔·英格海姆国际有限公司.手性8-(3-氨基哌啶-1-基)黄嘌呤的制备方法: 中国, 101048409A [P].2007-10-03., articleTitle=null, refAbstract=null), Reference(id=1329905867195002966, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=刘祥生, 张 毅, 张吉泉, 等.利格列汀的合成[J].中国医药工业杂志, 2016, 47(1): 4-7., articleTitle=null, refAbstract=null), Reference(id=1329905867283083351, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=ALLEGRINI P, ATTOLINO E, ARTICO M.Process for the preparation of linagliptin: EP, 2468749A1 [P].2012-06-27., articleTitle=null, refAbstract=null), Reference(id=1329905867354386520, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=ALLEGRINI P, ATTOLINO E, ARTICO M.Process for the preparation of linagliptin: US, 2012165525A1 [P].2012-06-28., articleTitle=null, refAbstract=null), Reference(id=1329905867408912473, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=隋立鹏, 牛晓亮, 宋 波, 等.一种利格列汀的制备方法:中国, 104672238B [P].2017-12-08., articleTitle=null, refAbstract=null), Reference(id=1329905867480215642, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=马 磊, 马玉楠, 等.遗传毒性杂质的警示结构[J].中国新药杂志, 2014, 23(18): 2106-2111., articleTitle=null, refAbstract=null), Reference(id=1329905867551518811, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=HUANG Y W, HE X Q, WU T Z, et al.Synthesis and characterization of process-related impurities of antidiabetic drug linagliptin [J].Molecules, 2016, 21(8): 1041., articleTitle=null, refAbstract=null), Reference(id=1329905867635404893, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=封明明.利格列汀的合成工艺及质量标准研究[D].长春:吉林大学硕士学位论文, 2018., articleTitle=null, refAbstract=null), Reference(id=1329905867710902366, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Boehringer Ingelheim International GmbH.Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions: WO, 2013010964 [P].2013-01-24., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329905863764062244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, xref=null, ext=[AuthorCompanyExt(id=1329905863772450853, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035), AuthorCompanyExt(id=1329905863780839462, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.09.003, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2025.09.003, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2025.09.003, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2025.09.003, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1757433600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
利格列汀的合成工艺及其有关物质研究
王兵 , 李震 , 夏林涛 , 迟永建 , 李忠 *
中国医药工业杂志 | 研究论文 2025,56(9): 1129-1138
收起
收藏切换
中国医药工业杂志 |研究论文 2025 , 56 (9) : 1129 -1138
利格列汀的合成工艺及其有关物质研究
全屏
[Author(id=1329905863852142632, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905863952805930, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, authorId=1329905863852142632, language=EN, stringName=Bing WANG, firstName=Bing, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905864082829355, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, authorId=1329905863852142632, language=CN, stringName=王兵, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035, bio={"content":"

王兵,硕士,工程师,从事药品合成工艺与质量研究。

"}, bioImg=null, bioContent=

王兵,硕士,工程师,从事药品合成工艺与质量研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905863764062244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, xref=null, ext=[AuthorCompanyExt(id=1329905863772450853, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035), AuthorCompanyExt(id=1329905863780839462, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035)])]), Author(id=1329905864204464173, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905864309321775, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, authorId=1329905864204464173, language=EN, stringName=Zhen LI, firstName=Zhen, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905864376430640, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, authorId=1329905864204464173, language=CN, stringName=李震, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905863764062244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, xref=null, ext=[AuthorCompanyExt(id=1329905863772450853, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035), AuthorCompanyExt(id=1329905863780839462, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035)])]), Author(id=1329905864443539506, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905864527425588, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, authorId=1329905864443539506, language=EN, stringName=Lintao XIA, firstName=Lintao, middleName=null, lastName=XIA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905864598728757, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, authorId=1329905864443539506, language=CN, stringName=夏林涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905863764062244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, xref=null, ext=[AuthorCompanyExt(id=1329905863772450853, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035), AuthorCompanyExt(id=1329905863780839462, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035)])]), Author(id=1329905864678420535, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905864795861049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, authorId=1329905864678420535, language=EN, stringName=Yongjian CHI, firstName=Yongjian, middleName=null, lastName=CHI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905864875552826, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, authorId=1329905864678420535, language=CN, stringName=迟永建, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905863764062244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, xref=null, ext=[AuthorCompanyExt(id=1329905863772450853, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035), AuthorCompanyExt(id=1329905863780839462, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035)])]), Author(id=1329905864967827516, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329905865085268030, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, authorId=1329905864967827516, language=EN, stringName=Zhong LI, firstName=Zhong, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905865211097151, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, authorId=1329905864967827516, language=CN, stringName=李忠, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905863764062244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, xref=null, ext=[AuthorCompanyExt(id=1329905863772450853, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035), AuthorCompanyExt(id=1329905863780839462, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905863084584993, companyId=1329905863764062244, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035)])])]
王兵, 李震, 夏林涛, 迟永建, 李忠*
作者信息
  • 烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035
通讯作者:
李忠,博士,工程师,从事药品合成工艺与质量研究。
作者简介:

王兵,硕士,工程师,从事药品合成工艺与质量研究。

Study on Synthesis Process of Linagliptin and Its Related Substances
Bing WANG, Zhen LI, Lintao XIA, Yongjian CHI, Zhong LI*
Affiliations
  • Yantai Key Lab. of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264035
出版时间: 2025-09-10 doi: 10.16522/j.cnki.cjph.2025.09.003
文章导航
收藏切换

对降血糖药利格列汀(1)的合成工艺进行了优化,并确定了各步关键工艺参数及产生的杂质。以8-溴-7-(2-丁炔基)-3-甲基黄嘌呤(3)为原料,经2步取代反应、脱保护得1粗品,经乙醇重结晶得1精品。总收率74.6%(以3计),HPLC纯度99.85%,单杂小于0.05%。该工艺将脱保护试剂改为三氟甲磺酸三甲基硅酯(TMSOTf),工艺稳定,操作简单,可大幅度减少1的二聚体杂质(即有关物质B)的生成,适合工业化生产。该研究合成了9个有关物质,其中有关物质A、C、D、E、F、G、H和I的合成路线为自主设计,可为1的质量控制提供一定的参考。

利格列汀  /  降血糖药  /  二肽基肽酶Ⅳ抑制剂  /  2型糖尿病  /  有关物质  /  合成工艺

The synthesis process of the antihyperglycemic drug linagliptin(1) was optimized, and the key process parameters for each step were determined, along with the impurities generated. Starting from 8-bromo-7-(but-2-yn-1-yl)-3-methylxanthine(3), crude 1 was obtained through a two-step substitution reaction and deprotection. The pure target 1 was afforded by recrystallization from ethanol with an overall yield of 74.6%(based on 3) and HPLC purity of 99.85%, while individual impurity below 0.05%. By replacing the deprotection reagent with trimethylsilyl trifluoromethanesulfonate(TMSOTf), the process was stabilized and simplified, significantly reducing the formation of the dimer impurity of 1 (namely related substance B). This optimized process was suitable for industrial production. Furthermore, nine related substances were synthesized, among which the synthetic routes of related substances A, C, D, E, F, G, H, and I were reported at the first time. This study is expected to provide a valuable reference for the quality control of 1 .

linagliptin  /  antihyperglycemics  /  dipeptidyl peptidaseⅣ inhibitor  /  type 2 diabetes  /  related substance  /  synthesis process
王兵, 李震, 夏林涛, 迟永建, 李忠. 利格列汀的合成工艺及其有关物质研究. 中国医药工业杂志, 2025 , 56 (9) : 1129 -1138 . DOI: 10.16522/j.cnki.cjph.2025.09.003
Bing WANG, Zhen LI, Lintao XIA, Yongjian CHI, Zhong LI. Study on Synthesis Process of Linagliptin and Its Related Substances[J]. Chinese Journal of Pharmaceuticals, 2025 , 56 (9) : 1129 -1138 . DOI: 10.16522/j.cnki.cjph.2025.09.003

参考文献 引证文献
排序方式:
[1]
ECKHARDT M, LANGKOPF E, MARK M, et al.8-(3-(R)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione, a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes [J].J Med Chem, 2007, 50(26): 6450-6453.
[2]
THOMAS L, ECKHARDT M E, LANGKOPF E, et al.(R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3- methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione(BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors [J].J Pharmacol Exp Ther, 2008, 325(1): 175-182.
[3]
PENNO G, GAROFOLO M, DEL PRATO S.Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injury [J].Nutr Metab Cardiovasc Dis, 2016, 26(5): 361-373.
[4]
LAJARA R.Use of the dipeptidyl peptidase-4 inhibitor linagliptin in combination therapy for type 2 diabetes [J].Expert Opin Pharmacother, 2012, 13(18): 2663-2671.
[5]
SHEU W H H, PARK S W, GONG Y, et al.Linagliptin improves glycemic control after 1 year as add-on therapy to basal insulin in Asian patients with type 2 diabetes mellitus[J].Curr Med Res Opin, 2015, 31(3): 503-512.
[6]
王 悦, 郭 珩, 岑均达, 等. 利格列汀合成路线图解[J].中国医药工业杂志, 2014, 45(11): 1093-1096.
[7]
Boehringer Ingelheim Pharma GmbH & Co.KG.Preparation of 8-[3-amino piperidin-1-yl] xanthines, the production thereof and the use of the same as medicaments:WO, 2004018468A2 [P].2004-03-04.
[8]
刘明媚, 李婉婷, 黄 强, 等.利拉利汀的合成工艺研究[J].中国药物化学杂志, 2015, 25(4): 275-279.
[9]
Boehringer Ingelheim International GmbH.Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines: WO, 2006048427 [P].2006-05-11.
[10]
贝林格尔·英格海姆国际有限公司.手性8-(3-氨基哌啶-1-基)黄嘌呤的制备方法: 中国, 101048409A [P].2007-10-03.
[11]
刘祥生, 张 毅, 张吉泉, 等.利格列汀的合成[J].中国医药工业杂志, 2016, 47(1): 4-7.
[12]
ALLEGRINI P, ATTOLINO E, ARTICO M.Process for the preparation of linagliptin: EP, 2468749A1 [P].2012-06-27.
[13]
ALLEGRINI P, ATTOLINO E, ARTICO M.Process for the preparation of linagliptin: US, 2012165525A1 [P].2012-06-28.
[14]
隋立鹏, 牛晓亮, 宋 波, 等.一种利格列汀的制备方法:中国, 104672238B [P].2017-12-08.
[15]
马 磊, 马玉楠, 等.遗传毒性杂质的警示结构[J].中国新药杂志, 2014, 23(18): 2106-2111.
[16]
HUANG Y W, HE X Q, WU T Z, et al.Synthesis and characterization of process-related impurities of antidiabetic drug linagliptin [J].Molecules, 2016, 21(8): 1041.
[17]
封明明.利格列汀的合成工艺及质量标准研究[D].长春:吉林大学硕士学位论文, 2018.
[18]
Boehringer Ingelheim International GmbH.Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions: WO, 2013010964 [P].2013-01-24.
2025年第56卷第9期
43
11
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2025.09.003
  • 接收时间:2025-02-17
  • 首发时间:2026-11-18
  • 出版时间:2025-09-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-02-17
基金
作者信息
    烟台药物研究所,烟台市纳米药物与高端制剂重点实验室,山东 烟台 264035

通讯作者:

李忠,博士,工程师,从事药品合成工艺与质量研究。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.09.003
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏